Qualified protein degradation is staying explored as an alternative technique in cancer, whereby the normal protein degradation procedure is co-opted for therapeutic applications. Just lately formulated novel molecules termed proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. 1 ligand binds to the ‘protein of https://www.directivepublications.org/journal-of-clinical-breast-cancer/